Status: Recruiting
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK of single, ascending oral doses (SAD) of BDHK-2009 (Part 1) and multiple oral doses (Part 2) of BDHK-200 in healthy adult participants.
Participants needed: 68
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Benethera (Shaoxing) Biotechnology Co., Ltd.Updated: Jun 8, 2026Locations: 1
Eligibility criteria
WOCBP is defined as any female who has experienced menarche and has not undergon... [+1]
1. As determined by the investigator, known or persistent psychiatric disorders...